Tower Research Capital (TRC)’s Pharming Group PHAR Stock Holding History

Tower Research Capital (TRC)’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-89	Closed	-$1K	–	6063
2021 Q2	$1K	Buy	+89	New	+$1.11K	﹤0.01%	5236

Other funds holding PHAR

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s PHAR Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Pharming Group (PHAR) in Q3 2021, closing a stake of 89 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in PHAR in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 4 funds tracked by Wall St. Rank hold PHAR as of Q3 2021.

Tower Research Capital (TRC) reported no remaining Pharming Group position as of Q3 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 89 Pharming Group shares in Q3 2021, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Pharming Group in Q2 2021 and held it in 1 quarter.
Tower Research Capital (TRC)'s Pharming Group position peaked at $1K in Q2 2021.
4 funds tracked by Wall St. Rank held Pharming Group as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.